OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Microbiology Reviews is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	306
Extracutaneous sporotrichosis	265
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	216
2025 Acknowledgment of CMR Reviewers	207
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	156
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	153
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives	150
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease	148
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	133
Viral infections and pathogenesis of glaucoma: a comprehensive review	124
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	121
Progression of antibiotic resistance in Neisseria meningitidis	113
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	109
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions	101
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	101
Mechanisms of microbial colonization in biofilm-associated infections of hemodialysis catheters and advances in surface modification technologies	96
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections	95
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	95
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	92
Review of BCG immunotherapy for bladder cancer	89
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory	88
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review	85
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	84
Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy	84
Neisseria gonorrhoeae vaccines: a contemporary overview	81

Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	80
The black aspergilli ( Aspergillus niger complex) and their role in human, animal, and plant diseases	75
Congenital Syphilis: a Review of Global Epidemiology	72
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms	71
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen	70
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”	69
Plasmodium vivax malaria in India: microbiological barriers to diagnosis, treatment, and elimination	67
Influence of fungi on epithelial homeostasis and role in inflammatory diseases	65
Gut microbiota-derived short-chain fatty acids (SCFAs): immunomodulatory effects and therapeutic potential in infections	61
Serratia species as paratransgenic vehicles: potential applications in vector-borne disease control	59
Advances in medical and surgical management of Acanthamoeba keratitis: a comprehensive review	59
Diagnosis, Management, and Future Control of Cholera	56
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	55
Bacterial and fungal infections in persons who inject drugs	54
An unintended consequence: a review of iatrogenic central nervous system mold infections and outbreaks	51
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi	51
The ecological dynamics of skin microbiota in skin health and diseases	51
Marburg virus disease: a comprehensive review	48
BCG therapy in bladder cancer and its tumor microenvironment interactions	45
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	45
Implementation of pathogen genomics in clinical microbiology laboratories	45
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	45
Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions	44
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	42
Plasmids in Neisseria gonorrhoeae : drivers of DoxyPEP failure and an emerging threat for current therapy	42
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	41
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	40
Harnessing the host response for precision infectious disease diagnosis	38
Artemisinin-resistant malaria	37
Agnostic Sequencing for Detection of Viral Pathogens	37
Mechanistic insights into the pathogenesis and therapeutic recalcitrance of Staphylococcus aureus osteomyelitis	37